ABIOMED, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1981-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.abiomed.com
Clinical Trials
36
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
- Conditions
- Heart FailureCardiogenic ShockReduced Ejection Fraction Heart Failure
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06965504
- Locations
- 🇺🇸
Tampa General Hospital, Tampa, Florida, United States
🇺🇸Abbott Northwestern, Minneapolis, Minnesota, United States
🇺🇸Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
- Conditions
- AMI Cardiogenic Shock
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT06964685
- Locations
- 🇺🇸
St. Joseph Hospital Orange, Orange, California, United States
🇺🇸Ascension via Christi, Wichita, Kansas, United States
🇺🇸New Mexico Heart, Albuquerque, New Mexico, United States
Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps
- Conditions
- Heart Failure
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06765226
- Locations
- 🇩🇪
Universitätsklinikum Heidelberg, Heidelberg, BW, Germany
🇩🇪Universitätsklinikum Düsseldorf, Düsseldorf, NRW, Germany
🇩🇪Herzzentrum Leipzig, Leipzig, Saxony, Germany
Impella RP Flex with Smart Assist
- Conditions
- Right Ventricular (RV) Dysfunction
- First Posted Date
- 2024-10-11
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06637644
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Pima Heart and Vascular, Tucson, Arizona, United States
🇺🇸Baptist Health Heart Failure and Transplant Institute, Little Rock, Arkansas, United States
Abiomed Impella RT-DAQ - Observational Study
- Conditions
- Cardiogenic Shock
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT06308055
- Locations
- 🇩🇪
Uniklinik RWTH Aachen, Aachen, NRW, Germany
🇩🇪UKSH Campus Kiel, Kiel, SH, Germany
🇩🇪Asklepios Klinik Altona, Hamburg, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
FDA Approves First Fully Implantable Artificial Heart for End-Stage Patients
The FDA has approved the AbioCor Implantable Replacement Heart, the first completely implantable artificial heart, for patients with severe heart failure who are ineligible for a heart transplant.